Related Experiment Video
Updated: Apr 23, 2026

14:23
Quantitative Measurement of Invadopodia-mediated Extracellular Matrix Proteolysis in Single and Multicellular Contexts
Published on: August 27, 2012
19.1K
INPP4B suppresses prostate cancer cell invasion
Cell Communication and Signaling : CCS
|September 25, 2014
Summary
Inositol polyphosphate-4-phosphatase type II (INPP4B) suppresses prostate cancer invasion and metastasis by inhibiting oncogenic PKC signaling. Restoring INPP4B expression is a potential therapeutic strategy for advanced prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Loss of INPP4B and PTEN phosphatases is common in metastatic prostate cancer.
- Reduced INPP4B expression correlates with poor prognosis and metastasis in prostate cancer.
Purpose of the Study:
- To investigate the role of INPP4B in suppressing prostate cancer invasion and metastasis.
- To elucidate the molecular mechanisms by which INPP4B exerts its tumor-suppressive effects.
Main Methods:
- Overexpression of INPP4B in invasive prostate cancer cells (PC-3).
- Global gene expression analysis to identify regulated genes.
- Inhibition of PI3K/Akt and PKC signaling pathways.
- Analysis of downstream targets like IL-8, PAK6, BIRC5, and COX-2.
Main Results:
- INPP4B expression suppressed prostate cancer cell invasion in vitro and in vivo.
- INPP4B regulated genes involved in cell adhesion, extracellular matrix, and cytoskeleton.
- INPP4B suppressed IL-8 and induced PAK6, while downregulating BIRC5 and COX-2 via PKC signaling.
- PI3K/Akt inhibition did not affect IL-8, but PKC inhibition mimicked INPP4B's effect on IL-8.
Conclusions:
- INPP4B acts as a novel suppressor of oncogenic PKC signaling in prostate cancer.
- INPP4B plays a crucial role in maintaining prostate epithelium homeostasis and inhibiting tumor metastasis.
Related Concept Videos
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity
4.3K
4.3K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules
32.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K
The Intrinsic Apoptotic Pathway
6.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K

